Both in Pharmaceuticals
Opko Health vs Damora Therapeutics
Over the past year OPK returned +12.7% and DMRA returned −20.2%; their daily moves had a correlation of 0.22.
OPK +12.7% DMRA −20.2%Growth of $1, one year, split-adjusted
| Metric | OPK | DMRA |
|---|---|---|
| Price | $1.77 | $22.42 |
| Market cap | $1.32B | $1.38B |
| Today | +2.91% | +1.54% |
| 1 month | +21.2% | +14.7% |
| 6 months | +58.0% | — |
| Year to date | +40.5% | — |
| 1 year | +26.4% | — |
| Revenue growth (YoY) | +4.3% | — |
| Gross margin | 48.9% | — |
| Net margin | −5.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | — |
| Net cash | -$46.5M | $540.5M |
| Dividend yield | — | — |
| Volatility (60d) | 57.6% | — |
| Short % of float | 9.3% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).